Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,800 Publications201,348 Funding7,267 Clinical research190

Loading search results…

Browse

Scholars8,800 Publications201,348 Funding7,267 Clinical research190

FiltersClear all

Status

Recruiting69
Not yet recruiting3
Enrolling by invitation5
Active, not recruiting50
Completed52
Terminated11

Study type

Interventional166
Observational24

Phase

Not applicable138
Not reported24
Phase 311
Phase 28
Phase 46
Phase 2/33

Investigator

Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6
Shmuel Chen6

Show all 50Show fewer

Department

Medicine83
Surgery31
Cardiothoracic Surgery11
Psychiatry11
Neurological Surgery10

Show all 17Show fewer

Condition

Atrial Fibrillation19
Heart Failure15
Stroke8
Cardiovascular Diseases7
Chronic Limb-Threatening Ischemia7

Intervention type

Device190
Drug807
Other202
Biological157
Procedure127
Behavioral83

Sponsor type

Industry139
WCM (investigator-initiated)31
Other academic18
Cooperative group1
NIH1

Start date

Has results posted41

Device×Clear all

Showing 161–180 of 190 studiesSort:

CompletedInterventional · Not applicableNCT04676022 ↗
A Randomized Controlled Study to Evaluate the Safety and Effectiveness of Boston Scientific Spinal Cord Stimulation (SCS) Systems in the Treatment of Chronic Low Back and/or Leg Pain With No Prior Surgeries
Neel MehtaPI
Intervention
Device: WaveWriter · Other: Conventional Medical Managament
Dates
Mar 2021 – Aug 2022

FiltersClear all

Status

Recruiting69
Not yet recruiting3
Enrolling by invitation5
Active, not recruiting50
Completed52
Terminated11

Study type

Interventional166
Observational24

Phase

Not applicable138
Not reported24
Phase 311
Phase 28
Phase 46
Phase 2/33

Investigator

Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Geoffrey W Bergman6
Shmuel Chen6

Show all 50Show fewer

Department

Medicine83
Surgery31
Cardiothoracic Surgery11
Psychiatry11
Neurological Surgery10

Show all 17Show fewer

Condition

Atrial Fibrillation19
Heart Failure15
Stroke8
Cardiovascular Diseases7
Chronic Limb-Threatening Ischemia7

Intervention type

Device190
Drug807
Other202
Biological157
Procedure127
Behavioral83

Sponsor type

Industry139
WCM (investigator-initiated)31
Other academic18
Cooperative group1
NIH1

Start date

Has results posted41

Device×Clear all

Showing 161–180 of 190 studiesSort:

CompletedInterventional · Not applicableNCT04676022 ↗
A Randomized Controlled Study to Evaluate the Safety and Effectiveness of Boston Scientific Spinal Cord Stimulation (SCS) Systems in the Treatment of Chronic Low Back and/or Leg Pain With No Prior Surgeries
Neel MehtaPI
Intervention
Device: WaveWriter · Other: Conventional Medical Managament
Dates
Mar 2021 – Aug 2022

Manish Ashwin Parikh4

Mehraneh Dorna Jafari2

David Leslie Carr-Locke1

Daniel Joseph Holzwanger1

Obstetrics and Gynecology6

Rehabilitation Medicine6

Otolaryngology Head and Neck Surgery1

Radiation Oncology1

Show all 50

Show fewer

Ischemic Stroke7
Coronary Artery Disease6
Aortic Valve Stenosis4
Arrhythmias, Cardiac4
Bradycardia4
Chronic Pain4
Depression4
Heart Diseases4
Liver Diseases4
Mitral Valve Insufficiency4
Atrioventricular Block3
Carcinoma, Hepatocellular3
Depressive Disorder, Major3
Depressive Disorder, Treatment-Resistant3
Heart Valve Diseases3
Neoplasms3
Prostatic Neoplasms3
Pulmonary Arterial Hypertension3
Tricuspid Valve Insufficiency3
Alzheimer Disease2
Angina Pectoris2
Anxiety Disorders2
Aortic Aneurysm, Thoracoabdominal2
Blood Loss, Surgical2
Cognitive Dysfunction2
Colonic Neoplasms2
Death, Sudden, Cardiac2
Dissection, Thoracic Aorta2
Fatigue2
Gastric Outlet Obstruction2
Heart Failure, Diastolic2
Hypertension2
Liver Neoplasms2
Lung Diseases, Interstitial2
Nail Diseases2
Obesity2
Parkinson Disease2
Peripheral Arterial Disease2
Recurrence2
Tachycardia, Ventricular2
Varicose Ulcer2
Vascular Diseases2
Venous Thrombosis2
Acute Coronary Syndrome1
Acute Kidney Injury1

Radiation

Diagnostic test31

Dietary supplement14

Combination product11

Genetic7

· Results posted

Sponsor

Boston Scientific Corporation

Chronic Pain

CompletedInterventional · Not applicableNCT04702451 ↗

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Seth H. GoldbargPI

Intervention: Procedure: Dispersion ablation + PVI · Device: VX1 · Procedure: PVI
Dates: Feb 2021 – Dec 2023· Results posted
Sponsor: Volta Medical

Atrial Fibrillation

CompletedInterventional · Not applicableNCT04790344 ↗

LUX-Dx Heart Failure Sensors in an Insertable Cardiac Monitor System Clinical Study (LUX-Dx TRENDS)

Reema BhattPI

Intervention: Device: Investigational LUX-Dx ICM Implant
Dates: Mar 2021 – Jul 2026
Sponsor: Boston Scientific Corporation

Heart Failure

TerminatedInterventional · Phase 2NCT04816604 ↗

An Open-label Extension Study Evaluating the Long-term Safety and Efficacy of Oral Inhalation of GB002 for the Treatment of WHO Group 1 Pulmonary Arterial Hypertension (PAH)

Irina SobolPI

Intervention: Drug: GB002 (seralutinib) · Device: Generic Dry Powder Inhaler
Dates: Apr 2021 – Sep 2026
Sponsor: Gossamer Bio

Pulmonary Arterial Hypertension

CompletedInterventional · Not applicableNCT04818541 ↗

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Shing Chiu WongPI

Intervention: Device: PPCI · Device: Cardiogenic shock
Dates: Jun 2021 – Jan 2023
Sponsor: Vivasure Medical Ltd.

Percutaneous Large Hole Vascular Closure

CompletedInterventional · Phase 2NCT04843930 ↗

Improving Cognitive Health in COVID-19 Survivors Through Digital Therapeutics

Faith GunningPI

Intervention: Device: AKL-T01
Dates: Jul 2021 – Feb 2023· Results posted
Sponsor: Weill Medical College of Cornell University

Cognitive DysfunctionCovid19

TerminatedObservationalNCT04870281 ↗

BIO-AffectDX Clinical Study

George ThomasPI

Intervention: Device: CRT-DX
Dates: May 2021 – Dec 2021
Sponsor: BIOTRONIK GmbH & Co.

Heart FailureAtrial FibrillationCardiac Resynchronization Therapy

CompletedInterventional · Phase 4NCT04941807 ↗

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Shari LipnerPI

Intervention: Device: Platelet-rich plasma · Device: Platelet-poor plasma
Dates: Mar 2021 – Apr 2023· Results posted
Sponsor: Weill Medical College of Cornell University

Nail Diseases

CompletedInterventional · Phase 3NCT04952610 ↗

An Open Label Extension Study of Etripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia

James E. IpPI

Intervention: Drug: Etripamil NS 70 mg · Device: Aptar Pharma Nasal Spray Bidose System
Dates: Dec 2021 – Apr 2026
Sponsor: Milestone Pharmaceuticals

Paroxysmal Supraventricular Tachycardia

TerminatedInterventional · Not applicableNCT04964297 ↗

Evaluation of Ability to Detect Bowel Gas During Laparoscopic Right Colectomy With Intracorporeal Anastomosis

Mehraneh Dorna JafariPI

Intervention: Device: Obtaining bowel gas samples
Dates: Aug 2021 – Apr 2024· Results posted
Sponsor: Weill Medical College of Cornell University

Crohn's Disease of Large IntestineMalignant Neoplasm of Colon

CompletedInterventional · Not applicableNCT04972097 ↗

Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-Risk Patient Population

Timothy McClurePI

Intervention: Device: Irreversible Electroporation
Dates: Mar 2022 – Aug 2024· Results posted
Sponsor: Angiodynamics

Prostate Cancer

CompletedInterventional · Not applicableNCT04985773 ↗

A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)

Shing Chiu WongPI

Intervention: Device: Lacrosse NSE ALPHA coronary dilatation catheter
Dates: Dec 2021 – Dec 2022· Results posted
Sponsor: Infraredx, Inc.

Coronary StenosisCoronary Artery StenosisIn-stent Restenosis

CompletedInterventional · Phase 2NCT04996797 ↗

A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Induction Therapy With PRA023 in Subjects With Moderately to Severely Active Ulcerative Colitis

Randy LongmanPI

Intervention: Drug: Tulisokibart · Device: Companion Diagnostic (CDx) Testing · Other: Placebo
Dates: Jul 2021 – Jun 2023· Results posted
Sponsor: Prometheus Biosciences, Inc

Ulcerative Colitis

CompletedInterventional · Not applicableNCT05044507 ↗

The Efficacy of a Frequency-tuned Electromagnetic Field Treatment in Facilitating the Recovery of Subacute Ischemic Stroke Patients - a Pivotal Study (THE "EMAGINE" STUDY)

Joel SteinPIAsad Riaz SiddiqiPI

Intervention: Device: BQ 2.0
Dates: Dec 2021 – Nov 2023
Sponsor: BrainQ Technologies, Ltd.

Ischemic Stroke

CompletedInterventional · Not applicableNCT05184985 ↗

Efficacy of TrueRelief as a Non-Pharmacological Alternative for Pain Relief in Supraspinatus Tendonitis

Vandana SoodPI

Intervention: Device: TrueRelief device · Device: Sham TrueRelief device
Dates: May 2022 – Jun 2023 (est.)
Sponsor: Weill Medical College of Cornell University

Supraspinatus TendinitisShoulder Pain

CompletedInterventional · Not applicableNCT05201495 ↗

A Clinical Evaluation of the Jewel P-WCD in Subjects at High Risk for Sudden Cardiac Arrest

Gioia TurittoPI

Intervention: Device: Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
Dates: Jan 2022 – Nov 2023· Results posted
Sponsor: Element Science, Inc.

Sudden Cardiac Arrest

CompletedInterventional · Not applicableNCT05251363 ↗

BIOTRONIK Conduction System Pacing With the Solia Lead

Christopher F LiuPI

Intervention: Device: Solia S lead
Dates: Dec 2022 – Jan 2024· Results posted
Sponsor: BIOTRONIK, Inc.

BradycardiaAtrioventricular BlockLeft Bundle-Branch Block+1 more

CompletedInterventional · Not applicableNCT05293639 ↗

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)

Christopher F LiuPI

Intervention: Device: Pulse Field Ablation
Dates: Apr 2022 – Dec 2023· Results posted
Sponsor: Biosense Webster, Inc.

Atrial Fibrillation

CompletedInterventional · Not applicableNCT05385952 ↗

A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery

Benjamin SamsteinPI

Intervention: Device: GATT-Patch (currently named ETHIZIA) · Drug: TachoSil
Dates: Aug 2022 – May 2024· Results posted
Sponsor: GATT Technologies B.V.

Intraoperative BleedingHemorrhage, SurgicalLiver Diseases

CompletedInterventional · Not applicableNCT05443594 ↗

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation

Jim W. CheungPI

Intervention: Device: Phase 1: FARAPULSE Ablation System · Device: Phase 2: FARAPULSE Ablation System
Dates: Feb 2023 – Feb 2025· Results posted
Sponsor: Boston Scientific Corporation

Persistent Atrial Fibrillation

‹ Prev 1 2 3 4 5 6 7 8 9 10 Next ›